These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36803651)

  • 1. The prevalence and treatment patterns of familial hypercholesterolemia among Thai patients with premature coronary artery disease.
    Nawaka N; Rattanawan C; Pussadhamma B; Wutthimanop A; Nuinoon M; Porntadavity S; Theansun W; Jeenduang N
    Postgrad Med; 2023 May; 135(4):410-417. PubMed ID: 36803651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial hypercholesterolemia in Chinese patients with premature ST-segment-elevation myocardial infarction: Prevalence, lipid management and 1-year follow-up.
    Auckle R; Su B; Li H; Xu S; Xie M; Song Y; Abdul Quddus M; Xu Y; Liu B; Che W
    PLoS One; 2017; 12(10):e0186815. PubMed ID: 29088271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence and management of familial hypercholesterolemia in patients with acute coronary syndrome in the Polish tertiary centre: Results from the TERCET registry with 19,781 individuals.
    Dyrbuś K; Gąsior M; Desperak P; Osadnik T; Nowak J; Banach M
    Atherosclerosis; 2019 Sep; 288():33-41. PubMed ID: 31319356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial hypercholesterolemia screening program in Bosnia and Herzegovina and cardiovascular morbidity.
    Pojskic L; Pojskic B
    Atherosclerosis; 2018 Oct; 277():278-281. PubMed ID: 30270059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and pharmacologic management of familial hypercholesterolemia in an unselected contemporary cohort of patients with stable coronary artery disease.
    De Luca L; Arca M; Temporelli PL; Colivicchi F; Gonzini L; Lucci D; Bosco B; Callerame M; Lettica GV; Di Lenarda A; Gulizia MM;
    Clin Cardiol; 2018 Aug; 41(8):1075-1083. PubMed ID: 30039543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial hypercholesterolaemia and coronary risk factors among patients with angiogram-proven premature coronary artery disease in an Asian cohort.
    Nazli SA; Chua YA; Mohd Kasim NA; Ismail Z; Md Radzi AB; Ibrahim KS; Kasim SS; Rosman A; Nawawi H
    PLoS One; 2022; 17(9):e0273896. PubMed ID: 36054188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, clinical features and prognosis of familial hypercholesterolemia in Chinese Han patients with acute coronary syndrome after a coronary event: a retrospective observational study.
    Kou H; Wang H; Liu P; Wang X; Zhu W; Jiang W; Hu X; Deng J
    BMC Cardiovasc Disord; 2024 Mar; 24(1):144. PubMed ID: 38443803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence and clinical characteristics of familial hypercholesterolemia among Chinese patients undergoing coronary angiography due to angina-like chest pain].
    Zhang HW; Li S; Guo YL; Zhu CG; Wu NQ; Liu G; Dong Q; Sun J; Li JJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Feb; 46(2):104-108. PubMed ID: 29495232
    [No Abstract]   [Full Text] [Related]  

  • 9. Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction.
    Singh A; Gupta A; Collins BL; Qamar A; Monda KL; Biery D; Lopez JAG; de Ferranti SD; Plutzky J; Cannon CP; Januzzi JL; Di Carli MF; Nasir K; Bhatt DL; Blankstein R
    J Am Coll Cardiol; 2019 May; 73(19):2439-2450. PubMed ID: 31097165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of familial hypercholesterolemia in premature coronary artery disease patients admitted to a tertiary care hospital in North India.
    Sawhney JPS; Prasad SR; Sharma M; Madan K; Mohanty A; Passey R; Mehta A; Kandpal B; Makhija A; Jain R; Mantri RR; Vivek BS; Manchanda SC; Verma IC
    Indian Heart J; 2019; 71(2):118-122. PubMed ID: 31280822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence Of familial hypercholeSTerolaemia (FH) in Italian Patients with coronary artERy disease: The POSTER study.
    Gulizia MM; Maggioni AP; Abrignani MG; Bilato C; Mangiacapra F; Sanchez FA; Piovaccari G; Montagna L; Marini M; De Biasio M; Averna M; Casula M; Colivicchi F; Fabbri G; Lucci D; Zampoleri V; Catapano AL;
    Atherosclerosis; 2020 Sep; 308():32-38. PubMed ID: 32823190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency and problems of statin therapy in patients with heterozygous familial hypercholesterolemia.
    Korneva V; Kuznetsova T; Julius U
    Atheroscler Suppl; 2019 Dec; 40():79-87. PubMed ID: 31818452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suboptimal consideration and management of potential familial hypercholesterolaemia in patients with suspected premature coronary artery disease.
    Yudi M; Omera L; McCubbery N; Dick S; Jayasinghe R; Hamilton-Craig I
    Singapore Med J; 2012 Mar; 53(3):174-8. PubMed ID: 22434290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of heterozygous familial hypercholesterolaemia and its impact on long-term prognosis in patients with very early ST-segment elevation myocardial infarction in the era of statins.
    Rallidis LS; Triantafyllis AS; Tsirebolos G; Katsaras D; Rallidi M; Moutsatsou P; Lekakis J
    Atherosclerosis; 2016 Jun; 249():17-21. PubMed ID: 27062405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, risk factor burden, and severity of coronary artery disease in patients with heterozygous familial hypercholesterolemia hospitalized for an acute myocardial infarction: Data from the French RICO survey.
    Farnier M; Salignon-Vernay C; Yao H; Chague F; Brunel P; Maza M; Brunet D; Bichat F; Beer JC; Cottin Y; Zeller M
    J Clin Lipidol; 2019; 13(4):601-607. PubMed ID: 31324593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of potential familial hypercholesteremia (FH) in 54,811 statin-treated patients in clinical practice.
    Catapano AL; Lautsch D; Tokgözoglu L; Ferrieres J; Horack M; Farnier M; Toth PP; Brudi P; Tomassini JE; Ambegaonkar B; Gitt AK
    Atherosclerosis; 2016 Sep; 252():1-8. PubMed ID: 27494444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of familial hypercholesterolemia on long-term outcomes in patients undergoing percutaneous coronary intervention.
    Tscharre M; Herman R; Rohla M; Piackova E; Vargas KG; Farhan S; Freynhofer MK; Weiss TW; Huber K
    J Clin Lipidol; 2019; 13(1):115-122. PubMed ID: 30344049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
    deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of lipoprotein(a) levels in familial hypercholesterolemia and coronary artery disease.
    Li S; Wu NQ; Zhu CG; Zhang Y; Guo YL; Gao Y; Li XL; Qing P; Cui CJ; Xu RX; Sun J; Liu G; Dong Q; Li JJ
    Atherosclerosis; 2017 May; 260():67-74. PubMed ID: 28351002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of familial hypercholesterolemia in patients with early-onset coronary artery disease admitted to a coronary care unit.
    Pang J; Poulter EB; Bell DA; Bates TR; Jefferson VL; Hillis GS; Schultz CJ; Watts GF
    J Clin Lipidol; 2015; 9(5):703-8. PubMed ID: 26350818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.